Skip to main content

Enrollment in the Health Benefits for Immigrant Adults (HBIA) program will be temporarily paused effective July 1, 2023.

Enrollment in the Health Benefits for Immigrant Seniors (HBIS) program will be temporarily paused effective Nov. 6, 2023.

Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Meeting Results for: March 20, 2013

Drug Name Review Type Committee Recommendation Prior Approval Status � Final Determination
Quillivant XR New Drug Initial Review Require Prior Approval Prior Approval Required
Xeljanz New Drug Initial Review Require Prior Approval Prior Approval Required
Aubagio New Drug Initial Review Require Prior Approval Prior Approval Required
Eliquis New Drug Initial Review Require Prior Approval Prior Approval Required
Sklice New Drug Initial Review Require Prior Approval Prior Approval Required
Gattex New Drug Initial Review Require Prior Approval Prior Approval Required
Oxtellar XR New Drug Initial Review Require Prior Approval Prior Approval Required
Tudzorza Pressair New Drug Initial Review Require Prior Approval Prior Approval Required
Natroba New Drug Appeal Require Prior Approval Prior Approval Required
Brilinta PDL Appeal Require Prior Approval Prior Approval Required
Latuda PDL Appeal Remove Prior Approval Requirement Prior Approval Requirement Removed